<Doctoral Thesis>
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma
Creator | |
---|---|
Examiner | |
Language | |
Academic Year Conferred | |
Conferring University | |
Degree | |
Degree Type | |
Publication Type | |
Access Rights | |
Related DOI |
Hide fulltext details.
File | FileType | Size | Views | Description |
---|---|---|---|---|
med3680 | 990 KB | 213 | 本文 | |
med3680_abstract | 65.0 KB | 128 | 要旨 | |
med3680_review | 81.5 KB | 110 | 審査結果要旨 |
Details
Record ID | |
---|---|
Peer-Reviewed | |
Rights | |
Related PubMed ID | |
Report Number | |
Number of Diploma | |
Granted Date | |
Date Accepted | |
Faculty | |
Created Date | 2023.05.16 |
Modified Date | 2023.07.31 |